UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Mediterranean diet supplemented with extra virgin olive oil or nuts improves endothelial markers involved in blood pressure control in hypertensive women

European journal of nutrition, 2017-02, Vol.56 (1), p.89-97

2017

Volltextzugriff (PDF)

Effect of extra virgin olive oil components on the arachidonic acid cascade, colorectal cancer and colon cancer cell proliferation

Grasas y aceites (Sevilla), 2016-12, Vol.67 (4), p.159-e159

2016

Volltextzugriff (PDF)

5-Hydroxyeicosatetraenoic acid and leukotriene D4 increase intestinal epithelial paracellular permeability

The international journal of biochemistry & cell biology, 2013-07, Vol.45 (7), p.1318-1326

2013

Volltextzugriff (PDF)

Specialized pro-resolvin mediators induce cell growth and improve wound repair in intestinal epithelial Caco-2 cell cultures

Prostaglandins, leukotrienes and essential fatty acids, 2022-12, Vol.187, p.102520-102520, Article 102520

2022

Volltextzugriff (PDF)

12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT) induces cell growth and improves barrier function through BLT2 interaction in intestinal epithelial Caco-2 cell cultures

Biochemical pharmacology, 2021-08, Vol.190, p.114663-114663, Article 114663

2021

Volltextzugriff (PDF)

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Clinical cancer research, 2015-06, Vol.21 (12), p.2771-2779

2015

Volltextzugriff (PDF)

Factors underlying metastatic breast cancer patients' perceptions of symptom importance: a qualitative analysis

European journal of cancer care, 2018-01, Vol.27 (1), p.e12540-n/a

2018

Volltextzugriff (PDF)

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

JAMA oncology, 2020-09, Vol.6 (9), p.1410

2020

Volltextzugriff (PDF)

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer

Clinical cancer research, 2023-08, Vol.29 (16), p.3101-3109

2023

Volltextzugriff (PDF)

Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence

Breast cancer research : BCR, 2022-07, Vol.24 (1), p.45-45, Article 45

2022

Volltextzugriff (PDF)

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR + Metastatic Triple-Negative Breast Cancer

Clinical cancer research, 2020-05, Vol.26 (9), p.2111-2123

2020

Volltextzugriff (PDF)

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

Annals of oncology, 1996-04, Vol.7 (4), p.347-353

1996

Volltextzugriff (PDF)

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer

Clinical cancer research, 2015-06, Vol.21 (12), p.2722-2729

2015

Volltextzugriff (PDF)

A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk

The Journal of nutrition, 2019-11, Vol.149 (11), p.1920-1929

2019

Volltextzugriff (PDF)

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing

Breast cancer research and treatment, 2014-01, Vol.143 (1), p.57-68

2014

Volltextzugriff (PDF)

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Breast cancer research : BCR, 2020-02, Vol.22 (1), p.22-22, Article 22

2020

Volltextzugriff (PDF)

Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

Journal of clinical oncology, 2021-07, Vol.39 (20), p.JCO2100280-2256

2021

Volltextzugriff (PDF)

RNA-Seq based gene expression profiling of baseline and on-treatment breast tumors to predict response to HER2-directed therapy, without chemotherapy (TBCRC026)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.530-530

2024

Volltextzugriff (PDF)

Abstract PS11-14: Advanced precision health resources in the Susan G Komen tissue bank at the IU simon comprehensive cancer center

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-14-PS11-14

2021

Volltextzugriff (PDF)

Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)

Journal of Nuclear Medicine, 2023-11, Vol.64 (11), p.1690-1696

2023

Volltextzugriff (PDF)

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

Journal of clinical oncology, 2019-03, Vol.37 (9), p.714-722

2019

Volltextzugriff (PDF)

Terminal Duct Lobular Unit Involution of the Normal Breast: Implications for Breast Cancer Etiology

JNCI : Journal of the National Cancer Institute, 2014-10, Vol.106 (10), p.1

2014

Volltextzugriff (PDF)

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

Breast cancer research and treatment, 2012-02, Vol.131 (3), p.907-914

2012

Volltextzugriff (PDF)

191P Correlation of early change in standardized uptake value (SUV) on positron emission tomography (PET/CT) with recurrence-free survival (RFS) and overall survival (OS) in patients with primary operable HER2-positive breast cancer (TBCRC026)

Annals of oncology, 2022-09, Vol.33, p.S623-S624

2022

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(24)
Female
(21)
Oncology
(21)
Middle Aged
(19)
Aged
(16)
Adult
(14)
Breast Cancer
(11)
Biological And Medical Sciences
(7)
Breast Neoplasms - Pathology
(7)
Cancer
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Chemotherapy
(6)
Medical Sciences
(6)
Risk Factors
(6)
Treatment Outcome
(6)
Triple Negative Breast Neoplasms - Drug Therapy
(6)
Triple Negative Breast Neoplasms - Pathology
(6)
Aged, 80 And Over
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Mediterranean diet supplemented with extra virgin olive oil or nuts improves endothelial markers involved in blood pressure control in hypertensive women

Effect of extra virgin olive oil components on the arachidonic acid cascade, colorectal cancer and colon cancer cell proliferation

5-Hydroxyeicosatetraenoic acid and leukotriene D4 increase intestinal epithelial paracellular permeability

Specialized pro-resolvin mediators induce cell growth and improve wound repair in intestinal epithelial Caco-2 cell cultures

12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT) induces cell growth and improves barrier function through BLT2 interaction in intestinal epithelial Caco-2 cell cultures

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Factors underlying metastatic breast cancer patients' perceptions of symptom importance: a qualitative analysis

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer

BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer

Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR + Metastatic Triple-Negative Breast Cancer

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer

A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

RNA-Seq based gene expression profiling of baseline and on-treatment breast tumors to predict response to HER2-directed therapy, without chemotherapy (TBCRC026)

Abstract PS11-14: Advanced precision health resources in the Susan G Komen tissue bank at the IU simon comprehensive cancer center

Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

Terminal Duct Lobular Unit Involution of the Normal Breast: Implications for Breast Cancer Etiology

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

191P Correlation of early change in standardized uptake value (SUV) on positron emission tomography (PET/CT) with recurrence-free survival (RFS) and overall survival (OS) in patients with primary operable HER2-positive breast cancer (TBCRC026)

Suchergebnisse filtern